RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Recordati Industria Chimica e Farmaceutica SpA Stock

Recordati Industria Chimica e Farmaceutica SpA ROA 2025

Recordati Industria Chimica e Farmaceutica SpA ROA

0.09

Ticker

REC.MI

ISIN

IT0003828271

WKN

A0EABR

In 2025, Recordati Industria Chimica e Farmaceutica SpA's return on assets (ROA) was 0.09, a 18.42% increase from the 0.08 ROA in the previous year.

Recordati Industria Chimica e Farmaceutica SpA Aktienanalyse

What does Recordati Industria Chimica e Farmaceutica SpA do?

Recordati Industria Chimica e Farmaceutica SpA is an Italian pharmaceutical company based in Milan. The company was founded in 1926 by Giovanni Recordati and now has branches in many countries worldwide. Recordati's business model is based on the development, production, and marketing of drugs for various therapeutic areas. The company focuses particularly on therapy areas such as cardiology, urology, gastroenterology, pneumology, and hematology. Recordati operates in four business areas: Innovative Medicines, OTC Medicines, Generics, and Licensed Products. In the area of innovative medicines, the company specializes in the development of new active substances for the treatment of rare diseases. In the OTC Medicines area, Recordati specializes in the manufacture and marketing of over-the-counter drugs used to treat mild to moderate complaints. The generics area includes the production and marketing of generic products with the aim of influencing price development in the market. In the Licensed Products area, Recordati collaborates with other companies and takes over the marketing of their products in certain regions. Some of Recordati's best-known products include Cariprazine (an antipsychotic), Urolith (a preventive treatment for kidney stones), Zanipress (a treatment for hypertension), and Fokusin (a treatment for benign prostatic hyperplasia). Recordati is also committed to improving access to life-saving medications worldwide. The company engages in collaborations with international organizations such as the Global Alliance for TB Drug Development and supports the WHO's "Target Product Profiles" initiative. In 2019, Recordati Industria Chimica e Farmaceutica SpA achieved sales of around 1.4 billion euros in over 90 countries. The company employs about 4,200 people worldwide, including approximately 500 researchers and developers. In terms of future direction, Recordati sees continued high potential for growth and expansion, particularly through targeted investments in research and development. The company relies on close cooperation with other partners within the industry and the exploration of new markets and therapeutic areas. Recordati Industria Chimica e Farmaceutica SpA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Recordati Industria Chimica e Farmaceutica SpA's Return on Assets (ROA)

Recordati Industria Chimica e Farmaceutica SpA's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Recordati Industria Chimica e Farmaceutica SpA's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Recordati Industria Chimica e Farmaceutica SpA's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Recordati Industria Chimica e Farmaceutica SpA’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Recordati Industria Chimica e Farmaceutica SpA stock

What is the Return on Assets (ROA) of Recordati Industria Chimica e Farmaceutica SpA this year?

The Return on Assets (ROA) of Recordati Industria Chimica e Farmaceutica SpA is 0.09 undefined this year.

What was the ROA of Recordati Industria Chimica e Farmaceutica SpA compared to the previous year?

The ROA of Recordati Industria Chimica e Farmaceutica SpA has increased by 18.42% compared to the previous year.

What consequences do high ROA have for investors of Recordati Industria Chimica e Farmaceutica SpA?

A high ROA is advantageous for investors of Recordati Industria Chimica e Farmaceutica SpA, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Recordati Industria Chimica e Farmaceutica SpA?

A low ROA can be unfavorable for investors of Recordati Industria Chimica e Farmaceutica SpA as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Recordati Industria Chimica e Farmaceutica SpA affect the company?

An increase in ROA of Recordati Industria Chimica e Farmaceutica SpA can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Recordati Industria Chimica e Farmaceutica SpA impact the company?

A reduction in the ROA of Recordati Industria Chimica e Farmaceutica SpA can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Recordati Industria Chimica e Farmaceutica SpA?

Some factors that can influence the ROA of Recordati Industria Chimica e Farmaceutica SpA include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Recordati Industria Chimica e Farmaceutica SpA important for investors?

The ROA of Recordati Industria Chimica e Farmaceutica SpA is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Recordati Industria Chimica e Farmaceutica SpA take to improve ROA?

To improve ROA, Recordati Industria Chimica e Farmaceutica SpA can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Recordati Industria Chimica e Farmaceutica SpA pay?

Over the past 12 months, Recordati Industria Chimica e Farmaceutica SpA paid a dividend of 1.17 EUR . This corresponds to a dividend yield of about 2.18 %. For the coming 12 months, Recordati Industria Chimica e Farmaceutica SpA is expected to pay a dividend of 1.25 EUR.

What is the dividend yield of Recordati Industria Chimica e Farmaceutica SpA?

The current dividend yield of Recordati Industria Chimica e Farmaceutica SpA is 2.18 %.

When does Recordati Industria Chimica e Farmaceutica SpA pay dividends?

Recordati Industria Chimica e Farmaceutica SpA pays a quarterly dividend. This is distributed in the months of June, December, June, December.

How secure is the dividend of Recordati Industria Chimica e Farmaceutica SpA?

Recordati Industria Chimica e Farmaceutica SpA paid dividends every year for the past 0 years.

What is the dividend of Recordati Industria Chimica e Farmaceutica SpA?

For the upcoming 12 months, dividends amounting to 1.25 EUR are expected. This corresponds to a dividend yield of 2.34 %.

In which sector is Recordati Industria Chimica e Farmaceutica SpA located?

Recordati Industria Chimica e Farmaceutica SpA is assigned to the 'Health' sector.

Wann musste ich die Aktien von Recordati Industria Chimica e Farmaceutica SpA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Recordati Industria Chimica e Farmaceutica SpA from 11/20/2024 amounting to 0.6 EUR, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.

When did Recordati Industria Chimica e Farmaceutica SpA pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Recordati Industria Chimica e Farmaceutica SpA in the year 2024?

In the year 2024, Recordati Industria Chimica e Farmaceutica SpA distributed 1.17 EUR as dividends.

In which currency does Recordati Industria Chimica e Farmaceutica SpA pay out the dividend?

The dividends of Recordati Industria Chimica e Farmaceutica SpA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Recordati Industria Chimica e Farmaceutica SpA

Our stock analysis for Recordati Industria Chimica e Farmaceutica SpA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Recordati Industria Chimica e Farmaceutica SpA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.